Molecule Details
| InChIKey | PCMGNEFMPPLRII-BZCFBNKFSA-N |
|---|---|
| Compound Name | (S)-4-Methylsulfanyl-2-{2-[((S)-3-methyl-2-{2-[3-((2E,7E)-3,8,12-trimethyl-trideca-2,7,11-trienyl)-3H-imidazol-4-yl]-acetylamino}-pentyl)-naphthalen-1-ylmethyl-amino]-acetylamino}-butyric acid |
| Canonical SMILES | CCC(C)[C@@H](CN(CC(=O)N[C@@H](CCSC)C(=O)O)Cc1cccc2ccccc12)NC(=O)Cc1cncn1C/C=C(\C)CCC/C=C(\C)CCC=C(C)C |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 8.55 |
| Source | ChEMBL;TTD_MultiTarget |
2D Structure
Activity Profile